About the author: Naomi Fried, PhD (@NaomiFried), is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation infrastructure consulting to healthcare stakeholders including pharma companies and providers. Her previous positions include the first Chief Innovation Officer at Boston Children’s Hospital, Biogen’s VP of Innovation and External Partnerships, and VP...
As we do every quarter, MobiHealthNews has rounded up our Q1 2016 coverage into a handful of longform stories. This section is on pharma. Skip ahead using these links to read Q1 digital health news roundups about providers, payers, M&A and funding.
Novartis
Novartis announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler...
As the first installment of the two-part series on digital health's impact on pharma, CEO Ryan Beckland addresses subject recruitment and patient data.
The recruitment and enrollment process for clinical trials for drug development is a major challenge for pharmaceutical companies. In fact, this phase alone consumes about one-third of the time allocated to the average clinical trial, and most...
For the more than six years that MobiHealthNews has been covering the world of mobile and digital health pharma has always been one group that seemed just ready to break in. While providers and even payors have publicly gotten their hands dirty experimenting with telemedicine, remote patient monitoring, and patient engagement apps, pharma has largely been moving in the shadows through investments...
Austin, Texas-based clinical trial recruitment company ePatientFinder raised nearly $2.6 million from Parsons & Whittemore and a group of angel investors. This brings the company's total funding to about $4 million. The company closed a $1.4 million round in May 2014, according to Austin Business Journal.
ePatientFinder has developed a service that helps physicians find suitable clinical...
The second quarter of the year is oftentimes a slow one as the summer months approach, but Q2 2014 was surprisingly busy for digital health on all fronts. Investment dollars are up. FDA clearances averaged two per month and a surprising FDA deregulation proposal dropped during the quarter, too. M&A was even stronger than it was in Q1, which was already a record quarter for such deals....
Norwalk, Connecticut-based medication adherence platform company HealthPrize has raised $3 million in a new round of funding led by Mansa Capital to help it expand globally. The investment firm has the option to invest an additional $2 million over the course of the next year, according to a report from Dow Jones. HealthPrize, founded in 2009, had previously raised about $4 million from angel...
A clinical trial app from the Cleveland Clinic.
Mobile health provides a large and serious opportunity for the improvement of clinical trials, but one that always seems to be just out of reach. It's something we've written about a few times before. But Joseph Kim, Director of Patient Recruitment and Engagement at Shire Pharmaceuticals, believes the way that patient drug trials need to innovate...
Proteus Digital Health
Out of all the digital health stakeholders, pharmaceutical companies have both one of the biggest opportunities and some of the most significant challenges to make the most of mobile and digital technologies. As such, while providers and payors have dived into the digital health world with gusto, moves from pharma have often been tentative. They are just now starting to...
For the past few years MobiHealthNews has published quarterly reports on the state of mobile and digital health, but moving forward those paid reports will take the form of Friday Exclusives -- the Friday edition of our daily newsletter -- and In-Depths on our website. They will be free for all to read thanks to our generous sponsors and advertisers.
Last week we published our Q1 2014 review and...
